Artículos por temáticas

Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease

Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A.

J Alzheimers Dis. 2015;45(4):1077-88. doi: 10.3233/JAD-142952.

A new delirium phenotype with rapid high amplitude onset and nearly as rapid reversal: Central Coast Australia Delirium Intervention Study

Regal PJ.

Clin Interv Aging. 2015 Feb 13;10:473-80. doi: 10.2147/CIA.S78206. eCollection 2015.

[How poor blood glucose values damage the brain]

Kern W.

MMW Fortschr Med. 2015 Mar 5;157(4):63, 65-6. doi: 10.1007/s15006-015-2776-0.

Hearing and music in dementia

Johnson JK, Chow ML.

Handb Clin Neurol. 2015;129:667-87. doi: 10.1016/B978-0-444-62630-1.00037-8.

On visual hallucinations and cortical networks: a trans-diagnostic review

Carter R, Ffytche DH.

J Neurol. 2015 Jul;262(7):1780-90. doi: 10.1007/s00415-015-7687-6. Epub 2015 Mar 13.

The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model

Puri V, Wang X, Vardigan JD, Kuduk SD, Uslaner JM.

Behav Brain Res. 2015;287:96-9. doi: 10.1016/j.bbr.2015.03.029. Epub 2015 Mar 20.

Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD)

Lattante S, Ciura S, Rouleau GA, Kabashi E.

Trends Genet. 2015 May;31(5):263-73. doi: 10.1016/j.tig.2015.03.005. Epub 2015 Apr 10.

A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye GA, Levinson E, Roberts JS; REVEAL Study Group.

Alzheimers Dement. 2015 Oct;11(10):1222-30. doi: 10.1016/j.jalz.2014.10.014. Epub 2014 Dec 9.

Physical activity and dementia: long-term follow-up study of adult twins

Iso-Markku P, Waller K, Kujala UM, Kaprio J.

Ann Med. 2015 Mar;47(2):81-7. doi: 10.3109/07853890.2014.994675. Epub 2015 Jan 22.

Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies

Lista S, Dubois B, Hampel H.

J Nutr Health Aging. 2015 Feb;19(2):154-63. doi: 10.1007/s12603-014-0515-3.

Dementia in 2014. Towards early diagnosis in Alzheimer disease

Nordberg A.

Nat Rev Neurol. 2015 Feb;11(2):69-70. doi: 10.1038/nrneurol.2014.257. Epub 2015 Jan 27.

The prevalence of depressive symptoms in frontotemporal dementia: a meta-analysis

Chakrabarty T, Sepehry AA, Jacova C, Hsiung GY.

Dement Geriatr Cogn Disord. 2015;39(5-6):257-71. doi: 10.1159/000369882. Epub 2015 Feb 4.

Impaired DNA damage repair as a common feature of neurodegenerative diseases and psychiatric disorders

Shiwaku H, Okazawa H.

Curr Mol Med. 2015;15(2):119-28. doi: 10.2174/1566524015666150303002556.

Burden of Behavioral and Psychiatric Symptoms in People Screened Positive for Dementia in Primary Care: Results of the DelpHi-Study

Thyrian JR, Eichler T, Hertel J, Wucherer D, Dreier A, Michalowsky B, Killimann I, Teipel S, Hoffmann W.

J Alzheimers Dis. 2015;46(2):451-9. doi: 10.3233/JAD-143114.

Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer's Disease?

Clerx L, Gronenschild EH, Echavarri C, Verhey F, Aalten P, Jacobs HI.

Curr Alzheimer Res. 2015;12(4):358-67. doi: 10.2174/1567205012666150324174813.